Blood and marrow transplant clinical trials network: Progress since the state of the science symposium 2007

Research output: Contribution to journalEditorial

9 Scopus citations

Abstract

Outcomes of hematopoietic cell transplantation continue to improve. New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from related and unrelated donors. In June 2007, the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) convened a State of the Science Symposium (SOSS) in Ann Arbor and identified 11 high priority clinical trials for the network to pursue. This article reviews both the status of those trials and the record of achievement of the BMT CTN as it convenes another SOSS in Grapevine, Texas in February 2014.

Original languageEnglish
Pages (from-to)149-153
Number of pages5
JournalBiology of Blood and Marrow Transplantation
Volume20
Issue number2
DOIs
StatePublished - Feb 2014
Externally publishedYes

Keywords

  • Acute lymphocytic leukemia
  • Acute myeloid leukemia
  • Biomarkers
  • Cell therapy
  • Chronic lymphocytic leukemia
  • Clinical trials
  • Clinical trials network
  • Crohn's disease
  • Graft-versus-host disease
  • Hemaphogocytic lymphohistiocytosis
  • Hematopoietic cell transplantation
  • Quality of life
  • T cell lymphoma

Fingerprint

Dive into the research topics of 'Blood and marrow transplant clinical trials network: Progress since the state of the science symposium 2007'. Together they form a unique fingerprint.

Cite this